Transcriptional Consequences of Topoisomerase InhibitionIrene Collins(National Cancer Institute), David Levens(National Cancer Institute)Molecular and Cellular BiologyDecember 1, 200110.1128/mcb.21.24.8437-8451.2001Cited by 117SaveCiteExport RISWatch citationsRelated PapersDrugging the “Undruggable” MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers|Cancer Research|2021|70Excessive MYC-topoisome activity triggers acute DNA damage, MYC degradation, and replacement by a p53-topoisome|Molecular Cell|2024|16